Innotive Diagnostics Secures £1 Million Grant from PACE

On November 26, 2025, Innotive Diagnostics, commonly known as InnotiveDx, announced it has received a £1 million grant from PACE. This funding supports the development of its rapid urinary tract infection (UTI) diagnostics system and the InnotiveUTI test. The grant aims to enhance innovations addressing infections with high antimicrobial resistance (AMR) risks.

UTIs account for over 20% of antibiotic prescriptions globally, fueling AMR and unexpected hospital admissions. InnotiveDx's technology offers Bacterial ID and antimicrobial susceptibility test results under 60 minutes, boasting 96% accuracy. The grant will further assess these prototypes with clinical specimens, paving the way for clinical trials.

James Mainwaring, Chief Commercial and Operating Officer at InnotiveDx, highlighted this grant as a testament to their team's dedication. PACE’s Programme Director, Dr. Beverley Isherwood, expressed enthusiasm for collaborating with InnotiveDx in advancing their groundbreaking technology.